PatWWhitworthJr.MDBreast Oncology

PubMed

• Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome i...
  James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul, Pond R Kelemen, Andrew Y Ashikari, Paul L Baron, Paul D Weinstein, Angela Mislowsky, Lau...> ;Surgical Oncology. 2022 Dec 1
• 5 citations
  Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
  Pat Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee, Carrie L Dul, Charles H Nash 3rd, Mary K Murray, Paul D Richards, Mark Gittleman, Raye Bu...> ;Annals of Surgical Oncology. 2022 Apr 4
• 5 citations
  High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-st...
  Jennifer A Crozier, Julie Barone, Pat Whitworth, Abraham Cheong, Robert Maganini, Jose Perez Tamayo, Patricia Dauer, Shiyu Wang, William Audeh, Annuska M Glas> ;Journal of Surgical Oncology. 2022 Mar 1
• 2 citations
  Correction to: The Clinical Utility of DCISionRTon Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery.
  Chirag Shah, Troy Bremer, Charles Cox, Pat Whitworth, Rakesh Patel, Anushka Patel, Eric Brown, Linsey Gold, David Rock, Lee Riley, Christy Kesslering, Sheree Brown, Ro...> ;Annals of Surgical Oncology. 2021 Dec 1
• 15 citations
  The Clinical Utility of DCISionRTon Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery.
  Chirag Shah, Troy Bremer, Charles Cox, Pat Whitworth, Rakesh Patel, Anushka Patel, Eric Brown, Linsey Gold, David Rock, Lee Riley, Christy Kesslering, Sheree Brown, Ro...> ;Annals of Surgical Oncology. 2021 Oct 1
• 5 citations
  Response to the article by Dietz et al. entitled "Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID­19 pandemic. The...
  Peter D. Beitsch, Pat Whitworth, Rakesh Patel> ;Breast Cancer Research and Treatment. 2020 May 26
• 1 citations
  Legacy genetic testing results for cancer susceptibility: how common are conflicting classifications in a large variant dataset from multiple practices?
  Kanhua Yin, Yuxi Liu, Basanta Lamichhane, John F. Sandbach, Gayle Patel, Gia Compagnoni, Richard H. Kanak, Barry Rosen, David P. Ondrula, Linda Ann Smith, Eric J. Brow...> ;Annals of Surgical Oncology. 2020 Apr 27
• 35 citations
  Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy.
  Sheila Weinmann, Michael C. Leo, Melanie Francisco, Charisma L. Jenkins, Todd Barry, Glen Leesman, Steven P. Linke, Pat Whitworth, Rakesh R. Patel, James Pellicane, Fr...> ;Clinical Cancer Research. 2020 Apr 27
• 4 citations
  Reply to M.S. Copur et al, A. Taylor et al, and P.S. Rajagopal et al
  Peter D. Beitsch, Kevin S. Hughes, Pat Whitworth> ;Journal of Clinical Oncology. 2019 Jun 27
• 24 citations
  Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers.
  Floris H. Groenendijk, Tina Treece, Erin Yoder, Paul L. Baron, Peter D. Beitsch, William Audeh, Winand N.M. Dinjens, René Bernards, Pat Whitworth> ;NPJ Breast Cancer. 2019 Apr 18
• Response to: "Intact Excision of Breast Lesions Using BLES™: Is There a Clinical Indication Yet?"
  Pat Whitworth> ;Annals of Surgical Oncology. 2019 Mar 15
• 209 citations
  Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
  Peter D. Beitsch, Pat Whitworth, Kevin S. Hughes, Rakesh R. Patel, Barry Rosen, Gia Compagnoni, P Baron, Rache M. Simmons, Linda Ann Smith, Ian Grady, Michael Kinney, ...> ;Journal of Clinical Oncology. 2019 Feb 20
• 3 citations
  Minimally Invasive Intact Excision of High-Risk Breast Lesions and Small Breast Cancers: The Intact Percutaneous Excision (IPEX) Registry
  Pat Whitworth, Steven M. Schonholz, Rogsbert F. Phillips, Yara Robertson, Antonio Carlos Sánchez Ruiz, Susan Winchester, Cathy Graham, Jean F. Simpson, Chloe Wernecke> ;Annals of Surgical Oncology. 2019 Feb 12
• 11 citations
  Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
  Frank A. Vicini, Chirag Shah, Pat Whitworth, Michael Walker> ;Lymphatic Research and Biology. 2018 Dec 13
• 22 citations
  Preventing Breast Cancer-Related Lymphedema in High-Risk Patients: The Impact of a Structured Surveillance Protocol Using Bioimpedance Spectroscopy.
  Pat Whitworth, Chirag Shah, Frank A. Vicini, Andrea Cooper> ;Frontiers in Oncology. 2018 Jun 12
• 32 citations
  Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gen...
  Michaela Tsai, Shelly S. Lo, William Audeh, Rubina Qamar, Raye Budway, Ellis G. Levine, Pat Whitworth, B Mavromatis, Robin Zon, Dwight Oldham, Sarah Untch, Tina Treece...> ;JAMA Oncology. 2018 Jan 11
• 27 citations
  Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
  Pat Whitworth, Andrea Cooper> ;The Breast Journal. 2018 Jan 1
• 917 citations
  Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0...
  Armando E. Giuliano, Karla V. Ballman, Linda M. McCall, Peter D. Beitsch, Meghan Brennan, Pond R. Kelemen, David W. Ollila, Nora M. Hansen, Pat Whitworth, Peter W. Blu...> ;JAMA. 2017 Sep 12
• 29 citations
  Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
  Peter D. Beitsch, Pat Whitworth, Paul L. Baron, Michael Rotkis, Angela Mislowsky, Paul Richards, Mary Murray, James Pellicane, Carrie L. Dul, Charles Nash, Lisette Sto...> ;Annals of Surgical Oncology. 2017 Apr 26
• 203 citations
  Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American Co...
  Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Rodrigo Franco Gonçalves, Souzan Sanati, Chad J. Creighton, Katherine DeSchryver, Erika C. Crouch, Amy Brink, Mark A. Wat...> ;Journal of Clinical Oncology. 2017 Apr 1
• 33 citations
  Impact of Payer Constraints on Access to Genetic Testing
  Pat Whitworth, Peter D. Beitsch, Christopher Arnell, Hannah C. Cox, Krystal Brown, John Kidd, Johnathan M. Lancaster> ;Journal of Oncology Practice. 2017 Jan 1
• 56 citations
  Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted b...
  Pat Whitworth, Peter D. Beitsch, Angela Mislowsky, James Pellicane, Charles Nash, Mary Murray, Laura A. Lee, Carrie L. Dul, Michael Rotkis, Paul L. Baron, Lisette Stor...> ;Annals of Surgical Oncology. 2017 Mar 1
• 300 citations
  Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: Long-Term Follow-Up f...
  Armando E. Giuliano, Karla V. Ballman, Linda M. McCall, Peter D. Beitsch, Pat Whitworth, Peter W. Blumencranz, A. Marilyn Leitch, Sukamal Saha, Monica Morrow, Kelly K....> ;Annals of Surgery. 2016 Sep 1
• 70 citations
  A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision
  Charles E. Cox, Scott Russell, Vanessa Prowler, Ebonie Carter, Abby Beard, A Mehindru, Peter W. Blumencranz, Kathleen G. Allen, Michael Portillo, Pat Whitworth, Kristi...> ;Annals of Surgical Oncology. 2016 Jul 28
• 11 citations
  Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures
  Peter D. Beitsch, Pat Whitworth, Paul L. Baron, James Pellicane, Tina Treece, Erin Yoder, Mark A. Gittleman> ;Annals of Surgical Oncology. 2016 Jul 6
• Join now to see all

Lectures

• Pathological complete response in basal subtype tumors to predict improved distant metastasis free survival in the NBRST trial. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018